Testing effectiveness (Phase 2)UnknownNCT04442984
What this trial is testing
FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)
Who this might be right for
Gastric Carcinoma Stage IVEsophagogastric Junction Adenocarcinoma Stage IV
Blokhin's Russian Cancer Research Center 326